913 filings
Page 18 of 46
8-K/A
f00dkmgnp7rzh shicic
13 May 20
Other Events
8:00am
8-K
x3nw60h5oseh82d2
12 May 20
Regulation FD Disclosure
1:42pm
8-K
2ok1gjmczdf8p
8 May 20
Regulation FD Disclosure
5:07pm
S-8
zpww3y2ljr2
23 Apr 20
Registration of securities for employees
9:28pm
EFFECT
fapojiwkn043n81x
17 Apr 20
Notice of effectiveness
12:15am
EFFECT
nmyz1j knzoacyb
17 Apr 20
Notice of effectiveness
12:15am
424B3
545jr9p
16 Apr 20
Prospectus supplement
5:22pm
8-K
ffctht
16 Apr 20
Jaguar Health Enters Deal with Atlas Sciences to Develop NP-500, a Jaguar Non-Core Plant-based Type II Diabetes Drug Candidate
8:31am
EFFECT
ri6ww5lm1gc1zkb
16 Apr 20
Notice of effectiveness
12:15am
424B3
z9d3b57
15 Apr 20
Prospectus supplement
5:21pm
CORRESP
j0blo5furdb
15 Apr 20
Correspondence with SEC
12:00am
CORRESP
umi5gm
13 Apr 20
Correspondence with SEC
12:00am
8-K
5kvwi
10 Apr 20
Other Events
5:00pm
UPLOAD
i5arth hgfjx
10 Apr 20
Letter from SEC
12:00am
D
f54zfl a6lbf57r1e
8 Apr 20
$720K in equity / Common Stock, sold $720K, 6 investors
12:00am
D
9tejgtz dt8r94
7 Apr 20
$2.03M in equity / Common Stock, sold $2.03M, 1 investor
5:29pm